BioLineRx, MaRS Innovation Sign Framework Collaboration Agreement
News May 17, 2016
BioLineRx Ltd has announced that it has signed a framework collaboration agreement with MaRS Innovation, the commercialization agent for fifteen of Toronto's top academic institutions. Under the terms of the agreement, BioLineRx intends to review innovative projects and assets of startup companies originating from MaRS Innovation's members, in order to identify in-licensing, co-development or other partnering opportunities.
Kinneret Savitsky, Ph.D., CEO of BioLineRx, said, "We are pleased to collaborate with MaRS Innovation, one of the largest technology transfer organizations in North America. MaRS Innovation represents and invests in early stage assets derived from 15 institutions in Ontario, Canada, including the University of Toronto and its 9 affiliated teaching hospitals. We view them as a valuable source of potential innovative technologies and look forward to working together towards the development of future therapies."
"BioLineRx has a proven track record of identifying promising early stage biomedical projects and successfully developing them through clinical stages," stated Dr. Raphael Hofstein, President and CEO, MaRS Innovation. "We believe that the combination of our pool of novel technologies and projects together with BioLineRx's drug development expertise and strategic collaborations with global players is a perfect match."
New Process to Differentiate Stem Cells into Nucleus Pulposus-Like CellsNews
Researchers at Washington University have developed a new way to transform human induced pluripotent stem cells into nucleus pulposus cells, which are the chief component of intervertebral discs.READ MORE
Horizon Enters into Partnership with Pirbright Institute to Improve Vaccine YieldsNews
Extends Horizon’s biomanufacturing capabilities into vaccine manufacture. Research supported by a grant from the Canadian International Development Research Centre, funded by the Bill and Melinda Gates foundation.READ MORE
"Superplatelets" Could Help Make Trauma More SurvivableNews
A University of British Columbia bioengineer has developed a potential strategy for endowing platelets with extra powers so they can rise to the occasion and continue coagulation.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018
29th International Conference on Public Mental Health and Neuroscience
Jul 16 - Jul 18, 2018